These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3659037)

  • 1. Deferred hormone treatment in prostate cancer.
    Hall RR
    Prog Clin Biol Res; 1987; 243B():439-40. PubMed ID: 3659037
    [No Abstract]   [Full Text] [Related]  

  • 2. The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.
    Servadio C
    Prog Clin Biol Res; 1987; 243B():449-53. PubMed ID: 3659039
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed hormonal therapy in advanced prostatic cancer.
    Zungri E; Salvador J; Chéchile G; Diaz I; Martinez E
    Prog Clin Biol Res; 1987; 243B():441-7. PubMed ID: 3659038
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring of prostate volume by ultrasound in hormonally treated prostate cancer.
    Brandt B; Menu G; el Khansa A; Lardennois B
    Prog Clin Biol Res; 1987; 243B():13-9. PubMed ID: 3309979
    [No Abstract]   [Full Text] [Related]  

  • 5. The questionable use of hormone therapy in advanced carcinoma of the prostate.
    Murphy GP; Slack NH
    Urol Clin North Am; 1980 Oct; 7(3):631-8. PubMed ID: 6161459
    [No Abstract]   [Full Text] [Related]  

  • 6. Endocrine therapy in the management of advanced prostatic cancer: the case for early initiation of treatment.
    Grayhack JT; Kozlowski JM
    Urol Clin North Am; 1980 Oct; 7(3):639-43. PubMed ID: 7456176
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal treatment of advanced disease: some newer aspects.
    Griffiths K; Eaton CL; Harper ME; Turkes A; Peeling WB
    Semin Oncol; 1994 Oct; 21(5):672-87. PubMed ID: 7939755
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors.
    Kraljić I; Tarle M
    Prog Clin Biol Res; 1987; 243B():521-5. PubMed ID: 3659050
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo selection of androgen-insensitive cells in R3327-G rat prostate tumors: diethylstilbestrol diphosphate treatment versus orchiectomy.
    Pollack A; Block NL; Stover BJ; Irvin GL; Fuentes MP; Claflin AJ; Malinin TI
    J Natl Cancer Inst; 1983 May; 70(5):907-14. PubMed ID: 6573535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine treatment of prostate cancer.
    Turkes AO; Griffiths K
    Prog Med Chem; 1989; 26():299-321. PubMed ID: 2532376
    [No Abstract]   [Full Text] [Related]  

  • 11. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete androgen blockade for the treatment of prostate cancer.
    Labrie F; Dupont A; Belanger A
    Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
    [No Abstract]   [Full Text] [Related]  

  • 13. Endocrine treatment of prostatic cancer.
    Pollen JJ
    Urology; 1983 Jun; 21(6):555-8. PubMed ID: 6868224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral orchiectomy in the management of stage D-2 prostate cancer.
    Guinan P; Firfer R; Targonski P; Rubenstein M
    Int Surg; 1993; 78(1):73-5. PubMed ID: 8473090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone chemotherapy for newly diagnosed patients with metastatic prostate cancer.
    Kubota Y; Nakada T; Suzuki Y; Iizima Y; Adachi Y; Hashimoto T
    Int Urol Nephrol; 1993; 25(5):469-74. PubMed ID: 8270375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current role of hormonal therapy in the clinical treatment of prostatic cancer.
    Brendler CB
    Semin Urol; 1988 Nov; 6(4):269-78. PubMed ID: 3068766
    [No Abstract]   [Full Text] [Related]  

  • 17. Androgen deprivation therapy for prostate cancer: current status and future prospects.
    Miyamoto H; Messing EM; Chang C
    Prostate; 2004 Dec; 61(4):332-53. PubMed ID: 15389811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early versus delayed endocrine treatment in metastatic prostatic cancer.
    Schröder FH
    Prog Clin Biol Res; 1989; 303():253-60. PubMed ID: 2674988
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
    Berenguer Sánchez A
    Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinoma of the prostate: reasons for endocrine treatment prior to symptomatic metastases.
    Chisholm GD
    Prog Clin Biol Res; 1990; 359():1-6; discussion 15-24. PubMed ID: 2284285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.